Rosiglitazone increases testosterone in hypogonadal type 2 diabetic men

1. Johnson JA , Trasino SE , Ferranti AW , Vasselli JR. Prolonged decrease in adipocyte size after rosiglitazone treatment in high- and low-fat fed rats. Obesity 2007;15:2653–63.

2. Singh R , Artaza JN , Taylor WE , Gonzalez-Cadavid NF , Bhasin S. Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway. Endocrinology 2003;144:5081–8.

3. Jones TH. Testosterone associations with erectile dysfunction, diabetes and the metabolic syndrome. European Urology (Suppl) 2007;6:847–57.

4. Cohen PG. The hypogonadal-obesity cycle. Medical Hypothesis 1999;52:49–51.